LUPIN LIMITED UNIT II

Company type: Factory

Company Introduction:

Lupin Limited Unit II is a manufacturing facility owned by Lupin Limited, a prominent Indian multinational pharmaceutical company. This unit operates as a factory dedicated to the production of various pharmaceutical products.

Lupin Limited is recognized globally as a leader in the pharmaceutical sector, engaged in the development, manufacturing, and marketing of a diverse portfolio of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company maintains a strong presence across numerous therapeutic segments, including cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infectives, and women's health.

As a manufacturing unit, Lupin Limited Unit II is integral to Lupin's extensive global supply chain, contributing to the company's mission of providing high-quality, affordable medicines to markets worldwide. Operations at Unit II are conducted in strict adherence to rigorous quality standards and regulatory compliance, which are paramount in the pharmaceutical industry.

Lupin Limited Unit II is a manufacturing facility that contributes to the company's extensive portfolio of pharmaceutical products. Lupin's products generally encompass:

Finished Dosage Forms:

Generic Formulations

Branded Formulations

Over-the-Counter OTC Products

Active Pharmaceutical Ingredients APIs

Biosimilars

Therapeutic Areas Covered:

Cardiovascular Diseases

Diabetology

Respiratory Disorders

Pediatric Health

Gastrointestinal Issues

Central Nervous System CNS Disorders

Anti-infectives

Women's Health

Oncology

Ophthalmology